HAVCR2 and B-cell chronic lymphocytic leukemia: In CLL, Gal-9 binding to its receptor TIM-3 on Th1 and Treg cells has been shown to suppress IL-2 production, inhibit Th1 cell expansion, and induce Th1 apoptosis [53,57,58].